πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 145 of 173

  1. US 7029838

    Prevascularized contructs for implantation to provide blood perfusion

    Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 7029911

    AFC1 and RCE1: isoprenylated CAAX processing enzymes

    Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 7030080

    Lymphotoxin-Ξ², lymphotoxin-Ξ² complexes, pharmaceutical preparations and therapeutic uses thereof

    Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 7030087

    Synthetic approach to designed chemical structures

    Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 7026155

    Method of reducing bacterial proliferation

    Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 7022484

    Methods for treating neuropathological states and neurogenic inflammatory states and methods for identifying compounds useful therein

    Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 7022712

    Solubilization of weak bases

    Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 7022720

    Synthetic diazonamides as novel anti-mitotic agents

    Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 7022882

    NMDA receptor channel blocker with neuroprotective activity

    Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 7022336

    Methods for attaching proteins to lipidic microparticles with high efficiency

    Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 7022834

    Isotopically labelled DNA

    Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 7018987

    Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

    Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 7018841

    Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles

    Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 7015037

    Multiponent adult stem cells and methods for isolation

    Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 7011965

    Compositions and methods for stimulating wound healing and fibroblast proliferation

    Expires Mon Mar 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 7008633

    Local regional chemotherapy and radiotherapy using in situ hydrogel

    Expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 7005512

    Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells

    Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 7005262

    Methods for detecting nucleic acids encoding human telomerase reverse transcriptase

    Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 7005129

    Non-toxic mutants of pathogenic gram-negative bacteria

    Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 7005424

    Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy

    Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 7005274

    Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass

    Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 7005411

    Method for modulating nerve cell function

    Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 7005269

    ERAAP modulators regulate immune responses

    Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 7001602

    Use of botulinum toxin therapy for urinary incontinence and related disorders

    Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 7001609

    Mucosal originated drug delivery systems and animal applications

    Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 7002002

    Abundant extracellular products and methods for their production and use

    Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 7001884

    Eglin c based drugs for treatment of disease

    Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 7001718

    Method of inhibiting pathogenicity of infectious agents

    Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6998513

    Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use

    Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6998117

    Cancer treatment with retroviral vectors comprising wild-type p53

    Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6998413

    Treatment of neoplasms with yujungamycins

    Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6995188

    S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer

    Expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6992071

    Methods for modulating phototoxicity

    Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6991921

    Hyaluronan synthase gene and uses thereof

    Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6991794

    Progenitor cell preservation factors and methods for and products of their use

    Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6989375

    Enhanced expression of transgenes

    Expires Mon Jan 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6989146

    Stress proteins and peptides and methods of use thereof

    Expires Mon Jan 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6989153

    Radiation sensitive liposomes

    Expires Mon Jan 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6987023

    DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use

    Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6987166

    Compositions and methods for the treatment of sepsis

    Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6987193

    Illudin analogs useful as antitumor agents

    Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6984522

    Isolation and use of solid tumor stem cells

    Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6984622

    Use of lipopolysaccharides to manage corneal infections and wounds

    Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6984619

    Method for protection against tumor metastasis formation

    Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6984487

    Cystic fibrosis gene

    Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6982080

    Hydroxyethyl starchβ€”containing polypeptide compositions

    Expires Mon Dec 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6982361

    Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal

    Expires Mon Dec 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6979555

    Hyaluronan receptor for endocytosis

    Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.